eHealth director sells 74K shares under plan

eHealth, Inc. (EHTH) reported that director Francis S. Soistman Jr. sold a total of 74,593 shares of common stock in two open-market or private transactions on August 31 and September 1, 2026.

Rhea-AI Filing Summary

eHealth, Inc. (EHTH) reported that director Francis S. Soistman Jr. sold a total of 74,593 shares of common stock in two open-market or private transactions on August 31 and September 1, 2026. The shares were sold at weighted average prices of $1.1377 (range: $1.12–$1.20) and $1.0531 (range: $0.941–$1.16), respectively. The company states these sales were effected under a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2026.

Insider Trade Summary 10b5-1

Net Seller: 74,593 shares

Net Sell 2 txns

Insider SOISTMAN FRANCIS S JR

Role Director

Sold 74,593 shs ($82K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F3	37,297	$1.0531	$39K
Sale	Common Stock F1, F2	37,296	$1.1377	$42K

Holdings After Transaction: Common Stock — 1,015,221 shares (Direct)

Footnotes (3)

1. F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2026.
2. F2. The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.12 to $1.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. F3. The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.941 to $1.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Total shares sold: 74,593 shares Shares sold on August 31, 2026: 37,296 shares Weighted average price on August 31, 2026: $1.1377 per share +3 more

6 metrics

Total shares sold 74,593 shares Common stock sales reported for August 31 and September 1, 2026

Shares sold on August 31, 2026 37,296 shares Open-market or private sale of common stock

Weighted average price on August 31, 2026 $1.1377 per share Sales executed in a range from $1.12 to $1.20

Shares sold on September 1, 2026 37,297 shares Open-market or private sale of common stock

Weighted average price on September 1, 2026 $1.0531 per share Sales executed in a range from $0.941 to $1.16

Rule 10b5-1 plan adoption date June 1, 2026 Date the reporting person adopted the trading plan used for these sales

Key Terms

Rule 10b5-1 trading plan, weighted average price, open market or private transaction

3 terms

Rule 10b5-1 trading plan regulatory

"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The price reported in Table I, Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open market or private transaction financial

"Sale in open market or private transaction"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did eHealth (EHTH) disclose in this Form 4?

The filing reports that director Francis S. Soistman Jr. sold a total of 74,593 shares of eHealth common stock in two transactions on August 31, 2026 and September 1, 2026.

How many eHealth (EHTH) shares were sold on each date?

On August 31, 2026, the director sold 37,296 shares. On September 1, 2026, he sold 37,297 shares, for a combined total of 74,593 shares.

What were the sale prices for the eHealth (EHTH) insider transactions?

For August 31, 2026, the weighted average sale price was $1.1377 per share, with trades between $1.12 and $1.20. For September 1, 2026, the weighted average was $1.0531, with trades between $0.941 and $1.16.

Were the eHealth (EHTH) insider sales made under a Rule 10b5-1 plan?

Yes. The company reports that the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2026, indicating they were pre-arranged under that plan.

What is the role of the person selling shares in this eHealth (EHTH) Form 4?

The reporting person, Francis S. Soistman Jr., is identified as a director of eHealth, Inc. in the Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 04:19 PM EDT Accepted by SEC EDGAR 09/02/2026 - 04:19 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SOISTMAN FRANCIS S JR

(Last) (First) (Middle)

C/O EHEALTH, INC.

9190 PRIORITY WAY WEST DR., SUITE 110

(Street)

INDIANAPOLIS INDIANA 46240

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
eHealth, Inc. [ EHTH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/31/2026		S(1)		37,296	D	$1.1377(2)	1,052,518	D
Common Stock	09/01/2026		S(1)		37,297	D	$1.0531(3)	1,015,221	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2026.

2. The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.12 to $1.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.941 to $1.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Sonwha Lee as attorney-in-fact for Francis S. Soistman	09/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)